WAM
AEON.WS

Warberg Asset Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Warberg Asset Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-53,500
Closed -$5.34K – 258
2023
Q4 		$5.34K Hold
53,500
– – ﹤0.01% 185
2023
Q3 		$8.03K Buy
+53,500
New +$7.59K ﹤0.01% 185

Other funds holding AEON.WS

DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Warberg Asset Management's AEON.WS Position: Q1 2024 in Review

Warberg Asset Management sold out of AEON Biopharma Inc (AEON.WS) in Q1 2024, closing a stake of 53,500 shares — an estimated $5.34K sold.

Warberg Asset Management first reported a position in AEON.WS in Q3 2023 and held it in 2 quarters. The position peaked at $8.03K in Q3 2023. 30 funds tracked by Wall St. Rank hold AEON.WS as of Q1 2024.

  • Warberg Asset Management reported no remaining AEON Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • Warberg Asset Management sold 53,500 AEON Biopharma Inc shares in Q1 2024, an estimated $5.34K.
  • Warberg Asset Management first reported a position in AEON Biopharma Inc in Q3 2023 and held it in 2 quarters.
  • Warberg Asset Management's AEON Biopharma Inc position peaked at $8.03K in Q3 2023.
  • 30 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q1 2024.

Based on Warberg Asset Management's 13F filing for Q1 2024, filed 6 May 2024.